BRANCHBURG, N.J.--(BUSINESS
WIRE)--Hydromer, Inc. (HYDI.OB - OTC BB; HDO - BSX), a New Jersey
biotech
company publicly traded since 1982, has developed a new biopolymer
matrix (F201) with superb lubricity, exceeding over 100 cycles of wet
abrasion tests with up to 94% friction reduction. The new polymer is
non-cytotoxic with excellent adhesion to PEBAX® Resins, Stainless
Steel, Polyurethane and much more. The very first potential
application would be in super slippery catheter placement guidewires.
Hydromer will be seeking medical device manufacturers to enter into
confidentiality agreements with non-analysis restrictions, submit
their guidewire samples for trial coating and provide feedback to
Hydromer. Hydromer expects this evaluation phase to help explore the
capabilities of this potentially new ground breaking technology. The
Company is in the process of filing a patent application on this
technology to protect its interests on a worldwide basis. This release
is not to be construed as an offer to sell any products or license any
art based on this new technology.
This release contains forward-looking statements,
including
statements regarding Hydromer's developments in biopolymer molecular
entities. These statements are subject to various risks and
uncertainties that could cause actual evaluations of this polymer to
differ from those anticipated. Clients, potential clients and
investors are cautioned not to place undue reliance on any
forward-looking statements in this release, and are strongly
encouraged to review Hydromer's Annual Report on Form 10-K for the
year ended June 30, 2006, which is on file with the Securities and
Exchange Commission.
Hydromer, Inc. is a technology-based company involved in
the
research and development, manufacture and commercialization of
specialized polymer and hydrogel products for medical device,
pharmaceutical, animal health, cosmetic, personal care, and industrial
uses. For the latest information about Hydromer, Inc. and its
products, please visit our web site at http://www.hydromer.com.